StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$24.91−2.21 (-8.15%)

Close on Nov 17, 2026Market cap $977.52MP/E –Yield –

Alto Neuroscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Alto Neuroscience's enterprise value was $865.63M on Nov 11, 2026, against $258.28M a year earlier. Over the last 3 years it ranged from -$100.18M to $1.01B, with a median of $124.75M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$865.63M+136.8%
2025Dec 31, 2025$365.59M–
2024Dec 31, 2024-$57.97M–

More Alto Neuroscience figures

See a number that looks wrong?